Radiopharm - Model PTPµ - Peptide Molecule Biomarker Radioactive Drugs

• A highly specific targeting agent for the detection, imaging and treatment of tumors.
• When combined with low level radiation, the PTPµ biomarker functions as a highly specific PET imaging agent.
• When combined with high energy radiation, the PTPµ biomarker works as a radiopharmaceutical theranostic to destroy tumours.
• In therapeutic mode, the biomarker labels tumor cells far away from the main tumor mass, achieving specific recognition of the full extent of an invasive tumor.
• The biomarker recognises PTPµ in multiple tumor types including brain and gynaecological tumors.
• Initial indication will focus on glioblastoma.

PRECLINICAL DATAPTPy-targeted agent detects tumor cells but not normal cells